NBRV - Nabriva Therapeutics EPS beats by $0.04 beats on revenue November, 12 2019 04:22 PM Nabriva Therapeutics plc Nabriva Therapeutics (NASDAQ:NBRV): Q3 GAAP EPS of -$0.24 beats by $0.04.More news on: Nabriva Therapeutics plc, Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...